A human STR site-specific target probe and its application in digital PCR quantification of genomic DNA
By designing human STR locus-specific target probes and combining them with a digital PCR platform, the problem of inaccurate STR locus quantification in forensic science has been solved, achieving precise STR locus quantification and improving the success rate and data quality of DNA analysis in forensic science.
Patent Information
- Application Number
- CN202611445737.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-17
- Publication Date
- 2026-11-17
AI Technical Summary
Existing DNA quantification methods in forensic science have strict requirements for template amount windows, and conventional methods cannot accurately quantify STR sites, leading to inaccurate or failed typing results. Furthermore, existing digital PCR technology lacks a specific target system applicable to STR sites.
A human STR site-specific target probe was designed and combined with a digital PCR platform to directly quantify STR sites through primer-probe combinations, achieving absolute copy number detection and avoiding the shortcomings of conventional methods.
This enables precise quantification of STR loci, improves the success rate and data quality of forensic DNA analysis, and ensures the accuracy and reliability of STR typing.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] This invention relates to the field of forensic DNA analysis technology, specifically to a human STR site-specific target probe and its application in digital PCR quantification of genomic DNA. Background Technology
[0002] In forensic DNA analysis, short tandem repeat (STR) genotyping has become a core method for individual identification, kinship determination, and mixed sample analysis due to its high discriminative power, high sensitivity, and high degree of standardization. However, the accuracy and reliability of STR genotyping results are highly dependent on the amount of template DNA used for amplification. Specifically, STR testing has stringent window requirements for template amount—typically, the optimal template range is 0.2–1 ng (equivalent to approximately 30–150 copies of the human diploid genome). Deviations in template amount from this window will trigger a series of technical problems: Insufficient template amount (less than 0.1 ng): Under low template amount DNA (Low Copy Number DNA, LCN-DNA) conditions, STR amplification is prone to allelic dropout, stochastic amplification bias, increased stutter peaks, and increased non-specific products, resulting in incomplete genotype profiles, allelic imbalance within loci, or random amplification, which seriously affects the quality of the genotype and may even produce incorrect alignment results.
[0003] Excessive template amount (above 1 ng): Excessive template amount can cause fluorescence signal oversaturation (pull-up / bleed-through), amplification product overload, resulting in increased baseline noise ratio, broadening of genotyping peaks or adjacent channel crosstalk, which also reduces genotyping quality and may interfere with the detection of secondary contributors in mixed samples.
[0004] Therefore, accurate quantification of extracted DNA samples before STR amplification is a crucial prerequisite for ensuring the quality of DNA data entered into the forensic science database and the reliability of case sample analysis.
[0005] Currently, the DNA quantification methods commonly used in forensic science laboratories mainly include: Ultraviolet (UV) spectrophotometry: This method measures total nucleic acid concentration based on absorbance at 260 nm, but it has poor accuracy and lacks the ability to specifically detect human genomic DNA. Real-world case samples often contain highly degraded or heavily contaminated trace amounts of DNA, and UV quantification results frequently overestimate the effective amount of human template, misleading subsequent STR amplification system configuration.
[0006] Real-time quantitative PCR (qPCR): This method specifically amplifies conserved regions of the human genome (such as RNase P, β-globulin, Alu sequences, etc.) and performs relative quantification using a standard curve. While this method improves species specificity, it has the following inherent limitations: ① It relies on a standard curve, requiring standards of known concentrations for reference; batch-to-batch variations and storage stability of these standards directly affect quantification accuracy. ② It has a limited dynamic range and poor reproducibility for low-copy samples. ③ It is susceptible to fluctuations in PCR amplification efficiency; residual inhibitors between different samples can accumulate in the quantification results. ④ It cannot provide absolute copy numbers, only an estimated value of "equivalent genomic count." ⑤ The targets are usually housekeeping genes outside of STR regions, which are not directly related to subsequent STR testing. These limitations often lead to mismatches between qPCR quantification results and the optimal template amount for actual STR amplification in practice. This can result in minor issues such as needing to repeatedly adjust amplification cycles or re-extract DNA, or even direct STR typing failure or incorrect data entry, wasting valuable case materials and delaying investigations.
[0007] In recent years, digital PCR (dPCR) technology, as a new generation of DNA quantification method, has emerged. By randomly dividing the reaction system into thousands to tens of thousands of independent microreaction units, it directly calculates the initial copy number of the target nucleic acid molecule through a process of "limiting dilution-endpoint detection-Poisson statistics," without relying on standard curves or reference materials. This offers significant advantages such as high precision, high tolerance to inhibitor interference, and the ability to provide absolute quantitative results. However, applying dPCR to human genomic DNA quantification in forensic science still faces a core technical bottleneck: the lack of a target system suitable for dPCR platforms that can specifically recognize the human genome and tolerate degraded samples. While common human-specific targets (such as multi-copy Alu elements) have high sensitivity, sequence variations or copy number polymorphisms between different copies may affect quantitative consistency; while single-copy housekeeping gene targets may result in lower quantification due to sequence breaks in degraded samples. Furthermore, forensic samples often contain PCR inhibitors, placing higher demands on the stability of dPCR microreaction units.
[0008] Short tandem repeats (STRs) are the most commonly used genetic markers for forensic DNA identification and kinship determination. They consist of multiple repeat units arranged in tandem, and the number of repeats varies significantly among individuals. DNA quantification results prior to STR genotyping have a significant impact on amplification balance and genotyping accuracy; therefore, establishing stable and reliable STR quantification methods has always been an important direction in the development of forensic technology.
[0009] STR sites have significant repetitive structural features (such as...) Figure 1As shown in the diagram, the number of repetitions of repeat units varies among different alleles. This means the target sequence structure is variable (and the length of the amplification product also varies accordingly). Since conventional TaqMan probes typically require target sequences to have good uniqueness and stability, directly designing probes in STR repeat regions or across the boundary between repeat regions and flanking sequences is easily affected by factors such as repeat number differences, sequence polymorphism, and PCR slippage. This can influence the amplification kinetics and the hybridization and hydrolysis efficiency of the fluorescent probe during amplification. Conventional Taq-Man probes usually select other conserved regions where primers and probes are easier to design.
[0010] However, STR genotyping targets the STR locus itself, while the quantitative target and genotyping target are located at different positions in the genome, making them completely disconnected. In degraded samples, the integrity of conserved regions cannot represent the amplifiability of STR regions, resulting in quantitative results that cannot accurately reflect the effective template amount of STR loci. Therefore, developing a precise dPCR quantification method that can directly target STR loci and utilize their sequence structural characteristics to design specific primers and probes is of great significance for achieving accurate quantification of DNA samples in forensic science and ensuring the quality of STR genotyping from the source. Summary of the Invention
[0011] The purpose of this invention is to provide a human STR site-specific target probe and its application in digital PCR quantification of genomic DNA.
[0012] In a first aspect, the present invention claims protection for a primer-probe combination for quantifying human genomic DNA.
[0013] The primer-probe combination for quantifying human genomic DNA claimed in this invention consists of a primer pair for amplifying the D10S1248 locus and a probe; the primer pair consists of primer 1 and primer 2, the nucleotide sequence of primer 1 is SEQ ID NO:1, the nucleotide sequence of primer 2 is SEQ ID NO:2; and the nucleotide sequence of the probe is SEQ ID NO:3.
[0014] Furthermore, in the primer-probe combination, the molar ratio of primer 1, primer 2, and probe is 10:10:3.
[0015] Furthermore, the probe is labeled with a fluorescent reporter group at its 5' end and a quencher group at its 3' end. In some embodiments of the present invention, the fluorescent reporter group is FAM and the quencher group is BHQ1.
[0016] Secondly, the present invention claims protection for a probe used for the quantification of human genomic DNA.
[0017] The probe for quantification of human genomic DNA claimed in this invention targets the D10S1248 locus, and its nucleotide sequence is SEQ ID NO:3.
[0018] Furthermore, the probe is labeled with a fluorescent reporter group at its 5' end and a quencher group at its 3' end. In some embodiments of the present invention, the fluorescent reporter group is FAM and the quencher group is BHQ1.
[0019] Thirdly, the present invention claims protection for a kit for quantifying human genomic DNA.
[0020] The kit for quantifying human genomic DNA claimed in this invention contains the primer-probe combination described in the first aspect above or the probe described in the second aspect above.
[0021] Furthermore, the kit may also include PCR reaction premix and / or DNA standards. Alternatively, the kit may also include DNA polymerase, dNTPs, PCR buffer, and / or DNA standards.
[0022] Furthermore, the PCR reaction premix may contain hot-start DNA polymerase, deoxynucleotide triphosphates (dNTPs), magnesium ions, and a reaction buffer. In some embodiments of the present invention, the PCR is digital PCR. Accordingly, the PCR reaction premix is Bio-Rad's QX200 ddPCR Supermix, or an equivalent product with the same component functions.
[0023] Fourthly, the present invention claims protection for the use of the primer-probe combination described in the first aspect above, the probe described in the second aspect above, or the kit described in the third aspect above in the quantification of human genomic DNA.
[0024] Furthermore, the quantification is digital PCR quantification.
[0025] Fifthly, the present invention claims a method for digital PCR quantification of human genomic DNA.
[0026] The digital PCR quantification method for human genomic DNA claimed in this invention may include the following steps: (A1) Extract DNA from the sample to be tested; (A2) Using the DNA obtained in (A1) as a template, prepare a digital PCR reaction system using the primer and probe combination described in the first aspect above, the probe described in the second aspect above, or the kit described in the third aspect above. (A3) Divide the reaction system into multiple microreaction units and perform PCR amplification; (A4) After amplification, the fluorescence signal of each microreaction unit is detected, the number of positive microreaction units is counted, and the copy number concentration of the target DNA (i.e., the D10S1248 locus) in the reaction system is calculated based on the Poisson distribution, and then the mass concentration of human genomic DNA in the sample to be tested is obtained.
[0027] Furthermore, in (A4), the copy number concentration of target DNA in the original sample can be calculated based on the ratio of template loading volume to total reaction volume, thereby obtaining the mass concentration of human genomic DNA in the sample to be tested.
[0028] Furthermore, the sample to be tested is a forensic sample, including but not limited to: bloodstains, semen stains, saliva stains, hair, tissue, or contact DNA samples.
[0029] Sixthly, the present invention claims a sample pretreatment method for human genomic DNA STR typing.
[0030] The sample pretreatment method for human genomic DNA STR typing claimed in this invention may include: quantifying the DNA to be tested using the method described in the fifth aspect above, and determining the template loading amount for the STR amplification reaction based on the quantification result.
[0031] The accuracy of STR genotyping results is highly dependent on the amount of amplification starting template, with the optimal template range typically being 0.2-1 ng. Among existing DNA quantification methods, ultraviolet spectrophotometry primarily reflects the total nucleic acid content of the sample, while sequence-specific quantification methods such as qPCR usually select relatively conserved genomic regions as detection targets. These targets are often not consistent with the specific STR loci in subsequent STR genotyping. For degraded samples, different genomic regions may exhibit varying degrees of integrity due to differences in fragment length and breakage location. Therefore, while conventional quantification results can reflect the overall DNA content or overall degradation status of the sample, they cannot directly provide the actual amount of intact, amplifiable template at a specific STR locus, potentially leading to discrepancies between the results and the actual effective template amount at the target STR locus. The quantification method described in the fifth aspect above directly targets the STR locus (D10S1248), and the quantification results directly reflect the amount of intact, amplifiable template at this STR locus. Since the quantitative target directly corresponds genomically to the D10S1248 locus in subsequent STR genotyping, and the two exhibit high consistency in template integrity, degradation degree, and amplification efficiency, the quantitative results of this invention can provide template quantity information more relevant to the local DNA integrity of this STR locus. Determining the template loading amount for the STR amplification reaction based on these quantitative results helps reduce insufficient or excessive template input caused by errors in effective template quantity estimation, providing a more direct and reliable quantitative basis for template quantity control in subsequent STR genotyping.
[0032] This invention innovatively designs specific targets for the structurally characteristic regions of STR sequences (these targets are highly conserved in the human genome, are single-copy, and possess sequence characteristics suitable for designing stable probes). A series of in-depth studies were conducted, ultimately resulting in the design of a specific probe and primer system spanning the STR repeat region and flanking sequences (composed of the primer pairs shown in SEQ ID NO:1 and 2 and the probe shown in SEQ ID NO:3). Combined with a digital PCR platform, a precise and absolute method for quantifying human genomic DNA was established. This method can directly output the optimal template copy number / quality range suitable for STR amplification, providing accurate and reliable template quantity control for subsequent STR genotyping, thereby significantly improving the first-pass success rate and data quality of forensic DNA analysis. Attached Figure Description
[0033] Figure 1 This is a schematic diagram showing that STR sites have significant repetitive structural features.
[0034] Figure 2 This is a 1D fluorescence amplitude scatter plot of human genomic DNA digital PCR detection using primer-probe P1 and primer-probe P2 combinations of the present invention, respectively. The horizontal axis represents the event number of the droplet detection sequence, and the vertical axis represents the fluorescence signal amplitude of a single droplet in channel 1 (Ch1, FAM channel). In the figure, gray dots represent negative droplets (containing no target DNA, with low fluorescence amplitude), and blue dots represent positive droplets (containing target DNA and successfully amplified, with high fluorescence amplitude). E06 and F06 are the detection wells for detecting standard DNA (9947A) using primer-probe P1 and primer-probe P2 combinations, respectively.
[0035] Figure 3 The STR typing results for the human standard genomic DNA (9947A) quantified by dPCR in Example 3 at 9.47 cp / μL (repeat 1). One deletion site was identified: deletion site 11 at locus D7S820.
[0036] Figure 4 The STR typing results for the human standard genomic DNA (9947A) quantified by dPCR in Example 3 at 9.47 cp / μL (repeat 2). One deletion site was identified: deletion site 11 at locus D16S539.
[0037] Figure 5 The results of STR typing of the human standard genomic DNA (9947A) quantified by dPCR at 9.47 cp / μL in Example 3 (repeated 3 times). No gene locus deletions were found.
[0038] Figure 6 This image shows the results of dPCR detection using probe P1 on a second-fold serial dilution of another human genomic DNA standard, 9948. The upper part is a concentration data table output by QuantaSoft software. The Sample column lists the sample names (9948-0.5 ng / μL, 9948-0.25 ng / μL, 9948-0.125 ng / μL, 9948-0.0625 ng / μL, 9948-0.03125 ng / μL), the Target column lists the detection target (D10-P1-FAM), and the Conc (copies / μL) column lists the target copy number concentration in the reaction system calculated by the software based on the Poisson distribution, which are 8.2, 4.2, 2.5, 1.24, and 0.61 cp / μL, respectively. The lower half is a 1D fluorescence amplitude scatter plot of the corresponding samples. The horizontal axis represents the event number of the droplet detection sequence, and the vertical axis represents the fluorescence signal amplitude of a single droplet in channel 1 (Ch1, FAM channel). In the figure, gray dots represent negative droplets (containing no target DNA, fluorescence amplitude below the threshold), blue dots represent positive droplets (containing target DNA and successfully amplified, fluorescence amplitude above the threshold), and the pink horizontal line represents the positive / negative determination threshold (5827). A06, F06, G06, C07, and F07 correspond to the detection wells of the five diluted samples mentioned above. As can be seen from the figure, positive and negative droplets of each concentration form clearly separated clusters, and the proportion of positive droplets decreases with decreasing template concentration, indicating that the probe can achieve stable and effective dPCR detection at different template concentrations. Detailed Implementation
[0039] The present invention will now be described in further detail with reference to specific embodiments. The given embodiments are merely illustrative of the invention and not intended to limit its scope. The embodiments provided below can serve as a guide for further improvements by those skilled in the art and do not constitute a limitation on the invention in any way.
[0040] Unless otherwise specified, the experimental methods used in the following examples are conventional methods, performed according to the techniques or conditions described in the literature in this field or according to the product instructions. Unless otherwise specified, the materials and reagents used in the following examples are commercially available.
[0041] Example 1: Design and synthesis of primers and probes for quantification of human genomic DNA The digital PCR primers and probes of this invention were designed and synthesized using the D10S1248 STR locus as a template. Specific primer and probe sequences are shown in Tables 1 and 2. The 5' and 3' ends of the probes were labeled with FAM and BHQ1, respectively.
[0042] Table 1. Primers used for amplifying the D10S1248 locus
[0043] Table 2. Probes used to bind to the D10S1248 locus
[0044] Note: Probe D10S1248-P1 (probe P1 for short) binds directly to the short tandem repeat region of D10S1248; Probe D10S1248-P2 (probe P2 for short) spans the STR repeat region and the flanking sequence.
[0045] Example 2: Preparation of dPCR systems for probes P1 and P2 and identification of their detection effects 1. Preparation of primer and probe system The primers D10S1248-F and D10S1248-R, and probes P1 and P2 designed and synthesized in Example 1 were prepared with TE solution to a concentration of 100 μmol / L, and then diluted with ultrapure water to a final concentration of 10 μmol / L.
[0046] 2. Construction of digital PCR system This embodiment utilizes the prepared specific primers and probes to detect human genomic DNA standard 9947A to verify the probe's detection performance. The specific detection process is as follows: (1) Dilute DNA standard 9947A to 1 ng / μL with ultrapure water.
[0047] (2) Using DNA standard 9947A as the amplification template, the amplification primers, probes and amplification reaction mixture (Bio-RadddPCR) were prepared. TM A premixed amplification system was prepared using Supermix: 2.0 μL each of forward and reverse primers (10 μmol / L), 0.6 μL of probe (10 μmol / L), 1.0 μL of template DNA (DNA standard 9947A), 10.0 μL of Supermix, and deionized water to a final volume of 20.0 μL. See Table 3.
[0048] Table 3. PCR System
[0049] (3) The premixed amplification system was processed using a droplet generation chip and a droplet generator (Bio-Rad QX200). TM The droplet generator was used to create water-in-oil microdroplets. Subsequently, the system within the microdroplets was subjected to digital PCR amplification (Bio-Rad T100). TMThermal Cycler).
[0050] The reaction program was as follows: 95℃, 5 min, Ramp 2℃ / s; 94℃, 30 s, Ramp 2℃ / s, 58℃, 60 s, Ramp 2℃ / s, 39 cycles; then 98℃, 10 min, Ramp 2℃ / s; stored at 4℃.
[0051] (4) Detection was performed using a microdroplet analyzer (Bio-Rad QX200TM Droplet Reader). QuantaSoft 1.7 software was used to collect fluorescence amplitude data of each microdroplet and generate a 1D fluorescence amplitude scatter plot.
[0052] The detection results of probe P1 are as follows Figure 2 As shown in the figure, under the same template conditions, when using probe P1, which completely targets the STR repeat unit, for dPCR detection, positive and negative droplets formed clear and stable distribution intervals in terms of fluorescence amplitude, and the separation boundary between positive and negative droplets was clear, resulting in effective detection results. In contrast, when using probe P2, which spans the STR repeat region and flanking sequences, the fluorescence amplitude distribution of positive droplets was relatively dispersed, and some positive and negative droplet intervals were close to or overlapped, leading to a decrease in the separation degree of positive and negative droplets. Overall, the separation degree of positive and negative droplets by probe P1 is significantly better than that by probe P2.
[0053] Example 3: Correlation verification between dPCR quantification results and STR typing results To verify the accuracy of the dPCR quantification method of the present invention, a correlation analysis was performed between the dPCR quantification results and the results of routine forensic STR typing.
[0054] The molecular weight of human haploid genomic DNA is approximately 3.3 pg. Based on this, a conversion relationship between copy number concentration and mass concentration can be established: 1 ng / μL human genomic DNA ≈ 303 copies / μL (cp / μL) haploid genome.
[0055] Human standard genomic DNA (9947A) was appropriately diluted and used as the test sample. Following the steps in Example 2, a dPCR reaction system was prepared using primers D10S1248-F / R and probe P1 designed and synthesized in Example 1 (Table 1). The reaction system was divided into multiple microreaction units for PCR amplification. After amplification, the fluorescence signal of each microreaction unit was detected, the number of positive microreaction units was counted, and the copy number concentration of the target DNA (D10S1248 locus) in the test sample was calculated based on the Poisson distribution. The quantitative result according to the method of the present invention was 9.47 cp / μL, which is converted to 0.03125 ng / μL human genomic DNA according to the above conversion relationship. Samples of this concentration were amplified using the VeriFiler Plus (VFP) STR typing kit (ThermoFisher, USA), and the detection was repeated three times.
[0056] The results are as follows Figures 3 to 5 As shown: In three repeated tests, all loci were successfully genotyped in the first test with no deletions; in the other two tests, only one locus showed amplification deletion in each test. This deletion pattern is consistent with the genotyping performance of 9947A standard DNA at a known concentration of 0.03125 ng / μL on the VFP kit. Since 0.03125 ng / μL is a low template concentration, a stochastic effect exists during STR amplification, which can lead to random deletions at individual loci. This phenomenon is directly related to the template concentration. The STR genotyping results of the dPCR quantitative samples of this invention are highly consistent with the genotyping performance of standards of the same mass concentration, indicating that the dPCR quantitative results of this invention can accurately reflect the content of effective human genomic DNA in the sample that can be used for STR genotyping. The quantitative results are strongly correlated with downstream STR amplification results and can be used for accurate quantification of forensic DNA samples.
[0057] Example 4: Validation of the stability and detection limit of dPCR quantification based on probe P1 This embodiment utilizes the specific primers (D10S1248-F, D10S1248-R) and probe P1 prepared in Example 1 to amplify and detect human genomic DNA standard 9948, in order to evaluate the performance of probe P1 in concentration gradient quantification of the human genome. The specific detection process is as follows: (1) Dilute DNA standard 9948 to 0.5 ng / μL with ultrapure water, and then perform serial two-fold dilutions of the template DNA at this concentration.
[0058] (2) Using DNA standard 9948 at different dilutions in step (1) as amplification templates, amplification primers, probes and amplification reaction mixture (Bio-Rad ddPCR) were prepared. TMThe following premixed amplification system was prepared using Supermix: 2.0 μL each of upstream and downstream primers (10 μmol / L), 0.6 μL of probe (10 μmol / L), 1.0 μL of template DNA (DNA standard 9948), 10.0 μL of Supermix, and deionized water to a final volume of 20.0 μL. See Table 4.
[0059] Table 4. PCR System
[0060] (3) The premixed amplification system was made into water-in-oil droplets using a droplet generation chip and a droplet generator (Bio-Rad QX200™ DropletGenerator). Subsequently, the system in the droplets was subjected to digital PCR amplification (Bio-Rad T100™ Thermal Cycler).
[0061] The reaction program was as follows: 95℃, 5 min, Ramp 2℃ / s; 94℃, 30 s, Ramp 2℃ / s, 58℃, 60 s, Ramp 2℃ / s, 39 cycles; then 98℃, 10 min, Ramp 2℃ / s; stored at 4℃.
[0062] (4) Use a microdroplet analyzer (Bio-Rad QX200) TM The Droplet Reader was used to detect the fluorescence signal of each droplet, and QuantaSoft 1.7 software (Bio-Rad) was used for data analysis: the fluorescence signal threshold was automatically set to distinguish between positive and negative droplets, the number of positive droplets and the total number of droplets in each sample were counted, and the copy number concentration (cp / μL) of the target DNA (D10S1248 locus) in the reaction system was calculated based on the Poisson distribution statistical model. Then, the copy number concentration of the target DNA in the original sample (i.e., the template) was converted according to the template loading volume.
[0063] Test results as follows Figure 6As shown. To investigate the stability of dPCR quantification of human genomic DNA using probe P1 in this invention. In this embodiment, DNA standard 9948 was serially diluted twofold. The results showed that as the dilution factor increased (0.5 ng / μL; 0.25 ng / μL; 0.125 ng / μL; 0.0625 ng / μL; 0.03125 ng / μL), the target copy number concentrations of D10S1248 in each reaction system were 8.2 cp / μL; 4.2 cp / μL; 2.5 cp / μL; 1.24 cp / μL; and 0.61 cp / μL, respectively. Based on the template loading volume, the copy number concentrations of the target DNA (D10S1248 locus) in DNA standard 9948 at different dilutions in step (1) were 164 cp / μL; 84 cp / μL; 50 cp / μL; 24.8 cp / μL; and 12.2 cp / μL, respectively, which is consistent with the gradient dilution trend. Based on the human haploid genome of approximately 3.3 pg (1 ng / μL ≈ 303 cp / μL), the measured values are basically consistent with the theoretical values. Furthermore, the method still conforms to the gradient quantification relationship at a low concentration of 0.03125 ng / μL, indicating that the method still has acceptable quantitative accuracy and detection stability even at a low detection limit.
[0064] The present invention has been described in detail above. Those skilled in the art will recognize that the invention can be practiced in a wide range of ways with equivalent parameters, concentrations, and conditions without departing from its spirit and scope, and without requiring unnecessary experiments. While specific embodiments have been provided, it should be understood that further modifications can be made to the invention. In summary, according to the principles of the invention, this application is intended to include any changes, uses, or improvements to the invention, including changes made using conventional techniques known in the art that depart from the scope disclosed herein.
Claims
1. A primer probe combination for human genomic DNA quantification, characterized by: The primer-probe combination consists of a primer pair and a probe for amplifying the D10S1248 locus; the primer pair consists of primer 1 and primer 2, the nucleotide sequence of primer 1 is SEQ ID NO:1, the nucleotide sequence of primer 2 is SEQ ID NO:2; the nucleotide sequence of the probe is SEQ ID NO:
3.
2. The primer probe combination of claim 1, wherein: In the primer-probe combination, the molar ratio of primer 1, primer 2 and probe is 10:10:
3.
3. A probe for quantification of human genomic DNA, characterized by: The probe targets the D10S1248 gene locus, whose nucleotide sequence is SEQ ID NO:
3.
4. The primer-probe combination or probe according to any one of claims 1-3, characterized in that: The probe is labeled with a fluorescent reporter group at its 5' end and a quencher group at its 3' end.
5. A kit for quantifying human genomic DNA, characterized in that: The kit contains the primer-probe combination or probe as described in any one of claims 1-4.
6. The reagent kit according to claim 5, characterized in that: The kit also includes PCR reaction premix and / or DNA standards.
7. The kit according to claim 5 or 6, characterized in that: The kit also includes DNA polymerase, dNTPs, PCR buffer, and / or DNA standards.
8. The use of the primer-probe combination, probe, or kit according to any one of claims 1-7 in the quantification of human genomic DNA; Furthermore, the quantification is digital PCR quantification.
9. A digital PCR quantification method for human genomic DNA, characterized in that: The method includes the following steps: (A1) Extract DNA from the sample to be tested; (A2) Using the DNA obtained in (A1) as a template, prepare a digital PCR reaction system using any of the primer-probe combinations, probes, or kits described in claims 1-7; (A3) Divide the reaction system into multiple microreaction units and perform PCR amplification; (A4) After amplification, the fluorescence signal of each microreaction unit is detected, the number of positive microreaction units is counted, the copy number concentration of target DNA in the reaction system is calculated based on the Poisson distribution, and then the mass concentration of human genomic DNA in the sample to be tested is obtained.
10. A sample preprocessing method for human genomic DNA STR typing, characterized in that: The method includes: quantifying the DNA to be tested using the method of claim 9, and determining the amount of template to be added for the STR amplification reaction based on the quantification results.
